Emerging infectious diseases and society

Emerging Infectious Diseases and Society

Volumn , Issue , 2010, Pages 1-191

  Washer, Peter ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85006064998     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1057/9780230277182     Document Type: Book

References (351)

1. Ahmad, D. (2000). Opium smoking, anti-Chinese attitudes, and the American medical community, 1850-1890. American Nineteenth Century History, 1, 53-68.
2. Aina, T. (1988). The myth of African promiscuity. In R. Sabatier (ed.), Blaming Others: Prejudice, Race and Worldwide AIDS. London: The Panos Institute, pp. 76-8.
3. Alcabes, P. (2009). Dread: How Fear and Fantasy Have Fueled Epidemics from the Black Death to Avian Flu. New York: Public Affairs.
4. Allen, S. (2002). Media, Risk and Science. Buckingham: Open University Press.
5. Altman, D. (1986). AIDS and the New Puritanism. London: Pluto Press.
6. Altman, S. & over 700 additional signatories (2005). An open letter to Elias Zerhouni. Science, 307, 1409-10.
7. Anderson, W. (1996). Immunities of Empire: Race, disease, and the new tropical medicine, 1900-1920. Bulletin of the History of Medicine, 70, 94-118.
8. Annas, G. (2003). Terrorism and human rights. In J. Moreno (ed.), In the Wake of Terror: Medicine and Morality in a Time of Crisis. Cambridge, MA: The MIT Press, pp. 33-51.
9. Armelagos, G., Brown, P. & Turner, B. (2005). Evolutionary, historical and political perspectives on health and disease. Social Science & Medicine, 61, 755-65.
10. Ashenberg, K. (2007). Clean: An Unsanitised History of Washing. London: Profile Books.
11. Ashraf, H. (2002). Bioterror and HIV dominate infectious disease meeting. The Lancet, 360, 1076.
12. Ayliffe, G. & English, M. (2003). Hospital Infection: From Miasmas to MRSA. Cambridge: Cambridge University Press.
13. Baehr, P. (2006). Susan Sontag, battle language and the Hong Kong SARS outbreak of 2003. Economy and Society, 35, 42-64.
14. Barber, B. (1995). Jihad vs. McWorld: Terrorism's Challenge to Democracy. New York: Random House.
15. Barde, R. (2003). Prelude to the plague: Public health and politics at America's Pacific gateway, 1899. Journal of the History of Medicine, 58, 153-86.
16. Barker, M. (1981). The New Racism: Conservatives and the Ideology of the Tribe. London: Junction Books.
17. Barrett, R., Kuzawa, C.W., McDade, T., & Armelagos, G.J. (1998). Emerging and re-emerging infectious diseases: The third epidemiologic transition. Annual Review of Anthropology, 27, 247-71.
18. Barry, J. (2005). The Great Influenza: The Epic Story of the Deadliest Plague in History. London: Penguin Books.
19. Bayer, R. & Colgrove, J. (2003). Rights and dangers: Bioterrorism and the ideologies of public health. In J. Moreno (ed.), In the Wake of Terror: Medicine and Morality in a Time of Crisis. Cambridge, MA: The MIT Press, pp. 51-75.
20. Beck, U. (1986). Risk Society: Towards a New Modernity. London: Sage Publications
21. Beck, U. (2000). What is Globalisation? Cambridge: Polity Press.
22. Beck, U. (2006). Living in the world risk society. A Hobhouse memorial lecture given at the London School of Economics and Political Science. Economy and Society, 35, 329-45.
23. Bell, M., Brown, T., & Faire, L. (2006). Germs, genes and postcolonial geographies: Reading the return of tuberculosis to Leicester, UK, 2001. Cultural Geographies, 13, 577-99.
24. Benatar, S. (2003). Global poverty and tuberculosis: Implications for ethics and human rights. In M. Gandy & A. Zumla (eds), The Return of the White Plague: Global Poverty and the 'New' Tuberculosis. London: Verso, pp. 222-36.
25. Bengtsson, T. (1999). The vulnerable child. Economic insecurity and child mortality in pre-industrial Sweden: A case study. European Journal of Population, 15, 117-51.
26. Berkelman, R. & Freeman, P. (2004). Emerging infections and the CDC response. In R. Packard, P. Brown, R. Berkelman & H. Frumkin (eds), Emerging Illness and Society: Negotiating the Public Health Agenda. Baltimore and London: The Johns Hopkins University Press, pp. 350-88.
27. Bhattacharjee, Y. (2008). FBI to request scientific review of its anthrax investigation. Science, 916, 1.
28. Blanc, L. & Uplekar, M. (2003). The present global burden of tuberculosis. In M. Gandy & A. Zumla (eds), The Return of the White Plague: Global Poverty and the 'New' Tuberculosis. London: Verso, pp. 95-111.
29. Blendon, R., Benson, J., DesRoches, C., Raleigh, E., & Taylor-Clark, K. (2004). The public's response to the severe acute respiratory syndrome in Toronto and the United States. Clinical Infectious Diseases, 38, 925-31.
30. Blumberg, B. (1977). Australia antigen and the biology of hepatitis B. Science, 197, 17-25.
31. Blumberg, B. (1988). Hepatitis B virus and the carrier problem. Social Research, 55, 401-12.
32. Blume, S. (2006). Anti-vaccination movements and their interpretations. Social Science & Medicine, 62, 628-42.
33. Bonanni, P. (1999). Demographic impact of vaccination: A review. Vaccine, 17, S125.
34. Booth, K. (2000). 'Just testing'. Race, sex and the media in New York's 'baby AIDS' debate. Gender and Society, 14, 644-61.
35. Boyce, T., Swedlow, D. & Griffin, P. (1996). Shiga toxin-producing Escherichia coli infections and hemolytic uremic syndrome. Seminars in Pediatric Infectious Diseases, 7, 258-64.
36. Boylston, A. (2002). Clinical investigation of smallpox in 1767. New England Journal of Medicine, 346, 1326-8.
37. Brandt, A. (1985). No Magic Bullet: A Social History of Venereal Disease in the United States since 1880. Oxford: Oxford University Press.
38. Brandt, A. (1988). AIDS and metaphor: Toward the social meaning of epidemic disease. Social Research, 55, 413-32.
39. Brashares, J., Arcese, P., Moses, K., Coppolillo, P., Sinclair, A. & Balmford, A. (2004). Bushmeat hunting, wildlife declines, and fish supply in West Africa. Science, 306, 1180-3.
40. Breugelmans, J., Zucs, P., Porten, K., Broll, S., Niedrig, M., Ammon, A. et al. (2004). SARS transmission and commercial aircraft. Emerging Infectious Diseases, 10, 1502-3.
41. Broadway, M. (2008). The social representation and reality of BSE's impact in North Central Alberta. The Canadian Geographer, 52, 451-65.
42. Brookes, R. (1999). Newspapers and national identity: The BSE/CJD crisis in the British press. Media Culture Society, 21, 247-63.
43. Brower, J. & Chalk, P. (2003). The Global Threat of New and Reemerging Infectious Diseases: Reconciling US National Security and Public Health Policy. Santa Monica, CA: RAND Corporation.
44. Brown, D. (1996). The 1990 Florida dental investigation: Theory and fact. Annals of Internal Medicine, 124, 255-6.
45. Bud, R. (1978). Strategy in American cancer research after World War II: A case study. Social Studies of Science, 8, 425-59.
46. Bud, R. (1998). Penicillin and the new Elizabethans. British Journal for the History of Science, 31, 305-33.
47. Bud, R. (2006). Penicillin: Triumph and the Tragedy. Oxford: Oxford University Press.
48. Buus, S. & Olsson, E. (2006). The SARS crisis:Was anyone responsible? The Journal of Contingencies and Crisis Management, 12, 71-81.
49. Campkin, B. (2007). Degradation and regeneration: Theories of dirt and the contemporary city. In B. Campkin & R. Cox (eds), Dirt: New Geographies of Cleanliness and Contamination. London and New York: IB Tauris, pp. 68-80.
50. Campkin, B. & Cox, R. (2007). Materialities and metaphors of dirt and cleanliness. In B. Campkin & R. Cox (eds), Dirt: New Geographies of Cleanliness and Contamination. London and New York: IB Tauris, pp. 1-11.
51. Cannon, G. (1995). Superbug: Nature's Revenge. Why Antibiotics can Breed Disease. London: Virgin Publishing.
52. Cantor, N. (2001). In theWake of the Plague: The Black Death and theWorld it Made. London: Pocket Books.
53. Carson, R. (1962). Silent Spring. New York: Fawcett Spring.
54. CDC (1981). Pneumocystis Pneumonia - Los Angeles. MMWR Weekly, 30, 250-2.
55. CDC (1987). Epidemiologic notes and reports update: Human immunodeficiency virus infections in health-care workers exposed to blood of infected patients. MMWR Weekly, 36, 285-9.
56. CDC (1994). Addressing Emerging Infectious Disease Threats: A Prevention Strategy for the United States. Atlanta: Center for Disease Control.
57. CDC (1998). Preventing Emerging Infectious Diseases: A Strategy for the 21st Century. Atlanta: Center for Disease Control.
58. CDC (2001). STDs among men who have sex with men. STD Surveillance - Special Focus Profiles, 2001, 65-9.
59. Chavers, S., Fawal, H. & Vermund, S. (2002). An introduction to emerging and reemerging infectious diseases. In F. Lashley & J. Durham (eds), Emerging Infectious Diseases: Trends and Issues. New York: Springer Publishing Company, pp. 3-22.
60. Chen, L. & Narasimhan, V. (2003). Human security and global health. Journal of Human Development and Capabilities, 4, 181-90.
61. Chiang, W. & Duann, R. (2007). Conceptual metaphors for SARS: 'War' between whom? Discourse and Society, 18, 579-602.
62. Childers, J. (2005). Foreign matter: Imperial filth. In W. Cohen & R. Johnson (eds), Filth: Dirt, Disgust and Modern Life. Minneapolis: University of Minnesota Press, pp. 201-24.
63. Childress, J. (2003). Triage in response to a bioterrorist attack. In J. Moreno (ed.), In the Wake of Terror: Medicine and Morality in a Time of Crisis. Cambridge, MA: The MIT Press, pp. 77-95.
64. Chirimuuta, R. & Chirimuuta, R. (1987). AIDS Africa and Racism. Derbyshire: Bretby.
65. Chubin, D. & Studer, K. (1978). The politics of cancer. Theory and Society, 6, 55-74.
66. Clarke, L., Chess, C., Holmes, R. & O'Neill, K. (2006). Speaking with one voice: Risk communication lessons from the US anthrax attacks. Journal of Contingencies and Crisis Management, 14, 160-9.
67. Classen, C., Howes, D., & Synnott, A. (1994). Aroma: The Cultural History of Smell. London and New York: Routledge.
68. Cliff, A. & Haggett, P. (2004). Time, travel and infection. British Medical Bulletin, 69, 87-99.
69. Cockburn, A. (1963). The Evolution and Eradication of Infectious Diseases. Baltimore: The Johns Hopkins Press.
70. Cohen, W. (2005). Locating filth. In W. Cohen & R. Johnson (eds), Filth: Dirt, Disgust and Modern Life. Minneapolis: University of Minnesota Press.
71. Collinge, J. (1999). Variant Creutzfeldt-Jacob disease. The Lancet, 354, 317-23. Committee on Smallpox Vaccination Program Implementation (2005). The Smallpox Vaccination Program: Public Health in an Age of Terrorism. Washington, DC: The National Academies Press.
72. Committee on Smallpox Vaccination Program Implementation (2005). The Smallpox Vaccination Program: Public Health in an Age of Terrorism. Washington, DC: The National Academies Press.
73. Corbin, A. (1986). The Foul and the Fragrant: Odor and the French Social Imagination. Leamington Spa: Berg.
74. Craddock, S. (1995). Sewers and scapegoats: Spatial metaphors of smallpox in nineteenth century San Francisco. Social Science & Medicine, 41, 957-68.
75. Craddock, S. (1998). Tuberculosis, tenements and the epistemology of neglect: San Francisco in the nineteenth century. ECUMENE, 5, 53-80.
76. Crawford, D. (2007). Deadly Companions: How Microbes Shaped our History. Oxford: Oxford University Press.
77. Cyranoski, D. (2001). Outbreak of chicken flu rattles Hong Kong. Nature, 412, 261.
78. Danzig, R. & Berkowsky, P. (1999). Why should we be concerned about biological warfare? In J. Lederberg (ed.), Biological Weapons: Limiting the Threat. Cambridge, MA: The MIT Press, pp. 9-14.
79. Davey, C. (2002). Hepatitis C. In F. Lashley & J. Durham (eds), Emerging Infectious Diseases: Trends and Issues. New York: Springer Publishing Company, pp. 151-60.
80. David, M. (2005). Science in Society. Basingstoke: Palgrave Macmillan.
81. Davis, M. (2005). The Monster at our Door: The Global Threat of Avian Flu. NewYork and London: The New Press.
82. Davis, M. (2006). Planet of Slums. London and New York: Verso.
83. Dealler, S. (1996). Lethal Legacy. BSE: The Search for the Truth. London: Bloomsbury Publishing.
84. Delaney, M. (2000). HIV, AIDS, and the distortion of science. Focus, 15, 1-6.
85. Demko, V. (1998). An analysis of media coverage of the BSE crisis in the United States. In S. Razan (ed.), The Mad Cow Crisis: Health and the Public Good. London: UCL Press, pp. 153-66.
86. Deng, I., Duku, O., Gillo, A., Idris, A., Lolik, P., el Tahir, B. et al. (1978). Ebola haemorrhagic fever in Sudan, 1976. Report of a WHO/International study team. Bulletin of the World Health Organization, 56, 247-70.
87. Department of Health (2004). Towards Cleaner Hospitals and Lower Rates of Infection: A Summary of Action. London: HMSO.
88. Dew, K. (1999). Epidemics, panic and power: Representations of measles and measles vaccines. Health, 3, 379-98.
89. Dismukes, W. (1996). Emerging and reemerging infections. The American Journal of Medicine, 100, 12-14.
90. Douglas, M. (1966). Purity and Danger: An Analysis of Concepts of Pollution and Taboo. London: Routledge and Kegan Paul Ltd.
91. Douglas, M. (1992). Risk and Blame. London: Routledge.
92. Douglas, M. & Wildavsky, A. (1982). Risk and Culture: An Essay on the Selection of Technological and Environmental Dangers. Berkeley and Los Angeles: University of California Press.
93. Dubos, R. (1959). Mirage of Health: Utopias, Progress and Biological Change. New Brunswick and London: Rutgers University Press.
94. Dubos, R. & Dubos, J. (1952). The White Plague: Tuberculosis, Man and Society. New Brunswick, NJ: Rutgers University Press.
95. Duerden, B. (2007). Confronting infection in the English National Health Service. Journal of Hospital Infection, 65, 23-6.
96. Eckenwiler, L. (2003). Emergency health professionals and the ethics of crisis. In J. Moreno (ed.), In the Wake of Terror: Medicine and Morality in a Time of Crisis. Cambridge, MA: The MIT Press, pp. 111-33.
97. Eichelberger, L. (2007). SARS and New York's Chinatown: The politics of risk and blame during an epidemic of fear. Social Science & Medicine, 65, 1284-95.
98. Elbe, S. (2008). Our epidemiological footprint: The circulation of avian flu, SARS, and HIV/AIDS in the world economy. Review of International Political Economy, 15, 116-30.
99. Eldridge, J., Kitzinger, J., & Williams, K. (1997). The Mass Media and Power in Modern Britain. Oxford: Oxford University Press.
100. Elias, N. (1939). The Civilising Process. (1994 ed.) Oxford: Blackwell Publishing.
101. Ellis, W. & Lashley, F. (2002). Ebola, Marburg and Lassa fevers. In F. Lashley & J. Durham (eds), Emerging Infectious Diseases: Trends and Issues. New York: Springer Publishing Company, pp. 113-28.
102. Enserink, M. (2008). Anthrax Investigation: Full-Genome Sequencing Paved the Way From Spores to a Suspect. Science, 321, 898-9.
103. Enserink, M. & Kaiser, J. (2005). Has biodefense gone overboard? Science, 307, 1396-8.
104. Fairchild, A. (2004). Policies of inclusion: Immigrants, disease, dependency, and American immigration policy at the dawn and dusk of the 20th century. American Journal of Public Health, 94, 528-39.
105. Fairchild, A. & Tynan, E. (1994). Policies of containment: Immigration in the era of AIDS. American Journal of Public Health, 84, 2011-22.
106. Farmer, P. (1997). Social scientists and the new tuberculosis. Social Science and Medicine, 44, 347-58.
107. Farmer, P. (1999). Infections and Inequalities: The Modern Plagues. Berkeley and Los Angeles: University of California Press.
108. Farmer, P. (2005). Pathologies of Power: Health, Human Rights and the New War on the Poor. Berkeley and Los Angeles: University of California Press.
109. Farrar, J. & Adegbola, R. (2005). Vietnam and the Gambia: Antibiotic resistance in developing countries. In G. Newton (ed.), Antibiotic Resistance: An Unwinnable War? London: The Wellcome Trust, pp. 32-4.
110. Fauci, A. (2006). Emerging and Re-emerging Infectious Diseases: The Perpetual Challenge 2005 Robert H Ebert Memorial Lecture. Milbank Memorial Fund. Available: www.milbank.org/reports/0601Fauci/0601Fauci.html.
111. Feldberg, G. (2006). Making history: TB and the public health legacy of SARS in Canada. In J. Duffin & A. Sweetman (eds), SARS in Context: Memory, History, Policy. Montreal: McGill-Queens University Press, pp. 105-20.
112. Fenner, F., Henderson, D.A., Arita, I., Jezec, Z., & Ladnyi, I. (1988). Smallpox and its Eradication. Geneva: World Health Organization.
113. Ferguson, J. (1999). Biological weapons and the US law. In J. Lederberg (ed.), Biological Weapons: Limiting the Threat. Cambridge, MA: The MIT Press, pp. 81-92.
114. Fisher, J.A. (1994). The Plague Makers. New York: Simon and Schuster.
115. Foucault, M. (1973). The Birth of the Clinic. London: Routledge.
116. Fry, A. & Besser, R. (2002). Legionellosis: Legionnaires' disease and Pontiac fever. In F. Lashley & J. Durham (eds), Emerging Infectious Diseases: Trends and Issues. New York: Springer Publishing Company, pp. 171-80.
117. Gainer, B. (1972). The Alien Invasion: The Origins of the Aliens Act of 1905. London: Heinemann Educational Books.
118. Gandy, M. (2003). Life without germs: Contested episodes in the history of tuberculosis. In M. Gandy & A. Zumla (eds), The Return of the White Plague: Global Poverty and the 'New' Tuberculosis. London: Verso, pp. 15-39.
119. Gardner, D. (2008). Risk: The Science and Politics of Fear. London: Virgin Books.
120. Garrett, L. (1995). The Coming Plague: Newly Emerging Diseases in a World out of Balance. New York: Penguin.
121. Garrett, L. (2001). The nightmare of bioterrorism. Foreign Affairs, 80, 76-89.
122. Giddens, A. (1990). The Consequences of Modernity. Cambridge: Polity Press.
123. Giddens, A. (1991). Modernity and Self-Identity. Stanford: Stanford University Press.
124. Gieger, H. (2001). Terrorism, biological weapons, and bonanzas: Assessing the real threat to public health. American Journal of Public Health, 91, 708-9.
125. Gilbert, P. (2005). Medical mapping: The Thames, the body and Our Mutual Friend. In W. Cohen & R. Johnson (eds), Filth: Dirt, Disgust and Modern Life. Minneapolis: University of Minnesota Press, pp. 78-102.
126. Goldacre, B. (2008). Bad Science. London: Harper Perennial.
127. Goozner, M. (2003, 30 September). Bioterror brain drain. The American Prospect. Available: www.prospect.org/cs/articles?article=bioterror_brain_drain.
128. Gostin, L., Sapsin, J., Teret, S., Burris, S., Mair, J., Hodge, J. et al. (2002). The Model State Emergency Health Powers Act: Planning for and response to bioterrorim and naturally occurring infectious diseases. Journal of the American Medical Association, 288, 622-8.
129. Gottlieb, M. (2001). AIDS - Past and future. New England Journal of Medicine, 344, 1788-91.
130. Gottlieb, M., Schanker, H., Fan, P., Saxon, A. &Weisman, J. (1981). Pneumocystis pneumonia - Los Angeles. New England Journal of Medicine, 305, 1425-31.
131. Gould, T. (1995). A Summer Plague: Polio and its Survivors. New Haven and London: Yale University Press.
132. Grant, W. (1997). BSE and the politics of food. In P. Dunleavy (ed.), Developments in British Politics. Basingstoke: Macmillan, pp. 342-54.
133. Gregory, J. & Miller, J. (1998). Science in Public: Communication, Culture and Credibility. New York and London: Plenum Trade.
134. Groom, A. & Cheek, J. (2002). Hantavirus pulmonary syndrome. In F. Lashley & J. Durham (eds), Emerging Infectious Diseases: Trends and Issues. New York: Springer Publishing Company, pp. 139-50.
135. Guillemin, J. (1999). Anthrax: The Investigation of a Deadly Outbreak. Berkeley: University of California Press.
136. Gwyn, R. (1999). 'Killer bugs', 'silly buggers' and 'politically correct pals': Competing discourses in health scare reporting. Health, 3, 335-45.
137. Haggett, P. (1994). Geographical aspects of the emergence of infectious diseases. Geografiska Annaler Series B, Human Geography, 76, 91-104.
138. Hahn, B. & Shaw, G. (2000). AIDS as a zoonosis: Scientific and public health implications. Science, 287, 607-14.
139. Hardy, A. (1993). The Epidemic Streets. Infectious Disease and the Rise of Preventative Medicine 1856-1900. Oxford: Clarendon Press.
140. Henderson, D.A. (1999). About the first national symposium on medical and public health response to bioterrorism. Emerging Infectious Diseases, 5, 491.
141. Henderson, D.A. & Fenner, F. (2001). Recent events and observations pertaining to smallpox virus destruction in 2002. Clinical Infectious Diseases, 33, 1057-9.
142. Henretig, F. (2001). Biological and chemical terrorism defense: A view from the 'front lines' of public health. American Journal of Public Health, 91, 718-20.
143. Herring, D. (2009). Viral panic, vulnerability and the next pandemic. In C. Panter-Brick & A. Fuentes (eds), Health, Risk, and Adversity: A Contextual View from Anthropology. Oxford: Berghahn Press, pp. 78-97.
144. Herzlich, C. & Pierret, J. (1984). Illness and Self in Society. Baltimore and London: John Hopkins Press.
145. Herzlich, C. & Pierret, J. (1989). The construction of a social phenomenon: AIDS in the French press. Social Science and Medicine, 29, 1235-42.
146. Heuveline, P., Guillot, M. & Gwatkin, R. (2002). The uneven tides of health transition. Social Science and Medicine, 55, 322.
147. Hewitt, J. & Schmid, M. (2002). Cryptosporidiosis. In F. Lashley & J. Durham (eds), Emerging Infectious Diseases: Trends and Issues. New York: Springer Publishing Company, pp. 83-92.
148. Hewlett, B. & Amola, P. (2003). Cultural contexts of Ebola in northern Uganda. Emerging Infectious Diseases, 9, 1242-8.
149. Heymann, D. (2003). The evolving infectious disease threat: Implications for national and global security. Journal of Human Development and Capabilities, 4, 191-207.
150. Hillis, D. (2000). Origins of HIV. Science, 288, 1757-9.
151. Hinchliffe, S. (2000). Living with risk: The unnatural geography of environmental crises. In S. Hinchliffe & K. Woodward (eds), The Natural and the Social: Uncertainty, Risk and Change. London and New York: Routledge, pp. 117-54.
152. Hinman, A. (1998). Global progress in infectious disease control. Vaccine, 16, 1116-21.
153. Hodge, J. & Gostin, L. (2003). Protecting the public's health in an era of bioterrorism: The model State Emergency Health Powers Act. In J. Moreno (ed.), In theWake of Terror: Medicine and Morality in a Time of Crisis. Cambridge, MA: The MIT Press, pp. 17-33.
154. Holtzclaw, B. (2002). Dengue fever. In F. Lashley & J. Durham (eds), Emerging Infectious Diseases: Trends and Issues. New York: Springer Publishing Company, pp. 103-12.
155. Hui, E. (2006). Reasons for the increase in emerging and re-emerging viral infectious diseases. Microbes and Infection, 8, 905-16.
156. Huminer, D., Rosenfeld, J., & Pitlik, S. (1987). AIDS in the pre-AIDS era. Reviews of Infectious Diseases, 9, 1102-8.
157. Ibrahim, M. (2005). The securitization of migration: A racial discourse. International Migration, 43, 163-87.
158. Illich, I. (1976). Limits to Medicine. Medical Nemesis: The Expropriation of Health. London: Marion Boyars.
159. Ingram, A. (2005). The new geopolitics of disease: Between global health and global security. Geopolitics, 10, 522-45.
160. Ingram, A. (2007). HIV/AIDS, security and the geopolitics of US-Nigerian relations. Review of International Political Economy, 14, 510-34.
161. James, S. & Sargent, T. (2006). The economic impacts of SARS and pandemic influenza. In J. Duffin & A. Sweetman (eds), SARS in Context: Memory, History, Policy. Montreal: McGill-Queen's University Press, pp. 175-96.
162. Jernigan, D., Ragunathan, P., Bell, B., Brechner, R., Breznitz, E., Butler, J. et al. (2002). Investigation of bioterrorism-related anthrax, United States, 2001: Epidemiological findings. Emerging Infectious Diseases, 8, 1019-28.
163. Jodelet, D. (1991). Madness and Social Representations. Hertfordshire: Harvester and Wheatsheaf.
164. Joffe, H. (1999). Risk and 'the Other'. Cambridge: Cambridge University Press.
165. Joffe, H. & Haarhoff, G. (2002). Representations of far-flung illnesses: The case of Ebola in Britain. Social Science & Medicine, 54, 955-69.
166. Joffe, H. & Lee, N. (2004). Social representation of a food risk: The Hong Kong avian bird flu epidemic. Journal of Health Psychology, 9, 517-33.
167. Johnson, P. & Mueller, J. (2002). Updating the Accounts: Global Mortality of the 1918-1920 'Spanish' Influenza Pandemic. Bulletin of the History of Medicine, 76, 105-15.
168. Johnson, R., Nahmias, A., Magder, L., Lee, F., Brooks, C., & Snowden, C. (1989). A seroepidemiologic survey of the prevalence of herpes simplex virus type 2 infection in the United States. New England Journal of Medicine, 321, 7-12.
169. Jones, E. (2004). A Matron's Charter: An Action Plan for Cleaner Hospitals Leeds: NHS Estates.
170. Jones, K., Patel, N., Levy, M., Storeygard, A., Balk, D., Gittleman, J. et al. (2008). Global trends in emerging infectious diseases. Nature, 451, 990-3.
171. Kadlec, R., Zellicoff, A., & Vrtis, A. (1999). Biological weapons control: Prospects and implications for the future. In J. Lederberg (ed.), Biological Weapons: Limiting the Threat. Cambridge, MA: The MIT Press, pp. 95-112.
172. Kanki, P., Alroy, J., & Essex, M. (1985). Isolation of T-lymphotrophic retrovirus related to HTLV-III/LAV in wild caught African green monkeys. Science, 230, 951-4.
173. Kaufmann, S. (2009). The New Plagues: Pandemics and Poverty in a GlobalizedWorld. London: Haus Publishing.
174. Khardori, N. (2002). Vancomycin-resistant Enterococci. In F. Lashley & J. Durham (eds), Emerging Infectious Diseases: Trends and Issues. New York: Springer Publishing Company, pp. 243-54.
175. King, E. (1993). Safety in Numbers. London & New York: Cassell.
176. King, N. (2002). Security, disease, commerce: Ideologies of postcolonial global health. Social Studies of Science, 32, 763-89.
177. King, N. (2003a). Immigration, race and geographies of difference in the tuberculosis pandemic. In M. Gandy & A. Zumla (eds), The Return of the White Plague: Global Poverty and the 'New' Tuberculosis. London: Verso, pp. 39-54.
178. King, N. (2003b). The influence of anxiety: September 11, bioterrorism, and American public health. Journal for the History of Medicine, 58, 441.
179. King, N. (2004). The scale politics of emerging diseases. Osiris, 19, 76.
180. Kingston, W. (2000). Antibiotics, invention and innovation. Research Policy, 29, 679-710.
181. Kitler, M., Gavinio, P. & Lavanchy, D. (2002). Influenza and the work of theWorld Health Organization. Vaccine, 20, S5-S14.
182. Kitzinger, J. (1995). The face of AIDS. In Representations of Health, Illness and Handicap. Chur, Switzerland: Harwood Academic Publishers, pp. 49-66.
183. Kitzinger, J. & Reilly, J. (1997). The rise and fall of risk reporting: Media coverage of human genetics research, 'false memory syndrome' and 'mad cow disease'. European Journal of Communication, 12, 319-50.
184. Kolata, G. (1999). Flu: The Story of the Great Influenza Pandemic of 1918 and the Search for the Virus that Caused it. New York: Touchstone.
185. Kraut, A. (1994). Silent Travellers: Germs, Genes, and the 'Immigrant Menace'. New York: Basic Books.
186. Kuiken, T., Fouchier, R., Rimmelzwaan, G. & Osterhaus, A. (2003). Emerging viral infections in a rapidly changing world. Current Opinion in Biotechnology, 14, 641-6.
187. Lacey, R. (1994). Mad Cow Disease: The History of BSE in Britain. England: Gypsela Publications.
188. Lamey, B. & Malemeka, N. (1982). Aspects cliniques et epidemiologiques de la cryptococcose a Kinshasa. Medecine Tropicale, 42, 507-11.
189. Lane, H. & Fauci, A. (2001). Bioterrorism on the home front: A new challenge for American medicine. Journal of the American Medical Association, 286, 2595-7.
190. Lang, T. (1998). BSE and CJD: Recent developments. In S. Razan (ed.), The Mad Cow Crisis: Health and the Public Good. London: UCL Press, pp. 65-85.
191. Larson, B., Nerlich, B., & Wallis, P. (2005). Metaphors and biorisks: The war on infectious diseases and invasive species. Science Communication, 26, 243-68.
192. Lashley, F. (2002). Cyclospora cayetanensis: Arriving via Guatemalan raspberries. In F. Lashley & J. Durham (eds), Emerging Infectious Diseases: Trends and Issues. New York: Springer Publishing Company, pp. 93-102.
193. Laurance, J. (2003, April 6). Focus: Something in the food. Independent on Sunday.
194. Lawrence, J., Kearns, R., Park, J., Bryder, L. & Worth, H. (2008). Discourses of disease: Representations of tuberculosis within New Zealand newspapers 2002- 2004. Social Science and Medicine, 66, 727-39.
195. Leach, J. (1998). Madness, metaphors and miscommunication: The rhetorical life of mad cow disease in Britain. In S. Razan (ed.), The Mad Cow Crisis: Health and the Public Good. London: UCL Press, pp. 119-30.
196. Lederberg, J. (1999). Biological Weapons: Limiting the Threat. Cambridge, MA: The MIT Press.
197. Lederberg, J., Shope, R., & Oaks, S. (1992). Emerging Infections: Microbial Threats to Health in the United States. Washington, DC: National Academy Press.
198. LeDuc, J., Childs, J., Glass, G. &Watson, A. (1993). Hantaan (Korean hemorrhagic fever) and related rodent zoonoses. In S.S. Morse (ed.), Emerging Viruses. New York and Oxford: Oxford University Press, pp. 149-58.
199. Lemert, C. (1987). Postmodernism Is Not What You Think. Oxford: Blackwell Publishers.
200. Levy, E. & Fischetti, M. (2003). The New Killer Diseases: How the Alarming Evolution of Mutant Germs Threatens Us All. New York: Crown Publishers.
201. Lewison, G. (2008). The reporting of the risks from severe acute respiratory syndrome (SARS) in the news media, 2003-2004. Health, Risk and Society, 10, 241-62.
202. Lewontin, R. & Levins, R. (2003). The return of old diseases and the appearance of new ones. In M. Gandy & A. Zumla (eds), The Return of the White Plague: Global Poverty and the 'New' Tuberculosis. London: Verso, pp. 1-6.
203. Livingstone, D. (1999). Tropical climate and moral hygiene: The anatomy of a Victorian debate. British Journal for the History of Science, 32, 93-110.
204. Lockerbie, S. & Herring, D. (2009). Global panic, local repercussions: Economic and nutritional effects of bird flu in Vietnam. In R. Hahn & M. Inhorn (eds), Anthropology and Public Health. Oxford: Oxford University Press, pp. 754-78.
205. Lupton, D. (1994). Moral Threats and Dangerous Desires: AIDS in the News Media. London: Taylor and Francis.
206. Lupton, D. (1999a). Archetypes of infection: People with HIV/AIDS in the Australian press in the mid 1990s. Sociology of Health and Illness, 21, 37-53.
207. Lupton, D. (1999b). Risk. London and New York: Routledge.
208. MacDougall, H. (2006). From Cholera to SARS: Communicable disease control procedures in Toronto 1832 to 2003. In J. Duffin & A. Sweetman (eds), SARS in Context: Memory, History, Policy. Montreal: McGill-Queen's University Press, pp. 79-104.
209. Martin, E. (1994). Flexible Bodies: Tracking Immunity in American Culture from the Days of Polio to the Age of AIDS. Boston: Beacon Press.
210. Mass, L. (2004). Hepatitis C and the news media: Lessons from AIDS. In R. Packard, P. Brown, R. Berkelman & H. Frumkin (eds), Emerging Illness and Society: Negotiating the Public Health Agenda. Baltimore and London: The Johns Hopkins University Press, pp. 388-405.
211. Masters, W., Johnson, V., & Kolodny, R. (1988). Crisis: Heterosexual Behaviour in the Age of AIDS. London: Weidenfeld and Nicolson.
212. Matricardi, P., Rosmini, F., Riondino, S., Fortini, M., Ferrigno, L., Rapicetta, M. et al. (2000). Exposure to foodborne and orofecal microbes versus airborne viruses in relation to atopy and allergic asthma: Epidemiological study. British Medical Journal, 320, 412-17.
213. Matsumoto, G. (2003). Anthrax powder: State of the art? Science, 302, 1492.
214. May, T. (2005). Funding agendas: Has bioterror defense been over-prioritized? The American Journal of Bioethics, 5, 34-44.
215. McKeown, T. (1976). The Modern Rise of Population. London: Edward Arnold.
216. Miller, D. (1999). Risk, science and policy: Definitional struggles, information management, the media and BSE. Social Science and Medicine, 49, 1239-55.
217. Miller, J., Engelberg, S., & Broad, W. (2001). Germs: Biological Weapons and America's Secret War. New York: Simon & Schuster.
218. Moeller, S. (1999). Compassion Fatigue: How the Media sell Disease, Famine, War and Death. New York and London: Routledge.
219. Moore, P., Harrison, L., Telzac, G., Ajello, G., & Broome, C. (1988). Group A meningococcal carriage in travelers returning from Saudi Arabia. Journal of the American Medical Association, 260, 2686-9.
220. Moreno, J. (2003). Introduction. In J. Moreno (ed.), In the Wake of Terror: Medicine and Morality in a Time of Crisis. Cambridge, MA: The MIT Press, pp. xv-xxxv.
221. Morse, S.S. (1992a). Examining the origins of emerging viruses. In S.S. Morse (ed.), Emerging Viruses. Oxford: Oxford University Press, pp. 10-28.
222. Morse, S.S. (1992b). Preface. In S.S. Morse (ed.), Emerging Viruses. Oxford: Oxford University Press, pp. i.
223. Morse, S.S. (1995). Factors in the emergence of infectious diseases. Emerging Infectious Diseases, 1, 7-15.
224. Moulin, A. (2000). The defended body. In R. Cooter & J. Pickstone (eds), Medicine in the Twentieth Century. Amsterdam: Harwood Academic, pp. 385-98.
225. Muraskin, W. (1993). Hepatitis B as a model (and anti-model) for AIDS. In V. Berridge & P. Strong (eds), AIDS and Contemporary History. Cambridge: Cambridge University Press, pp. 108-34.
226. Myers, G., MacInnes, K. & Myers, L. (1992). Phylogenetic moments in the AIDS epidemic. In S.S. Morse (ed.), Emerging Viruses. New York and Oxford: Oxford University Press, pp. 120-37.
227. National Intelligence Council (2000). The Global Infectious Disease Threat and its Implications for the United States Washington, DC: CIA.
228. National Science and Technology Council (1995). Global Microbial Threats in the 1990s: Report of the NSTC Committee on International Science, Engineering and Technology (CISET) Working Group on Emerging and Re-emerging Infectious Diseases. Washington, DC: CISET.
229. Nelkin, D. & Gilman, S. (1988). Placing blame for devastating disease. Social Research, 55, 361-78.
230. Nerlich, B. & Koteyko, N. (2008). Balancing food risks and food benefits: The coverage of probiotics in the UK national press. Sociological Research Online, 13, 1-16.
231. O'Conner, E. (2000). Raw Material: Producing Pathology in Victorian Culture. Durham and London: Duke University Press.
232. O'Toole, T. & Inglesby, T. (2003). Toward biosecurity. Biosecurity and Bioterrorism: Biodefense Strategy, Practice and Science, 1, 1.
233. O'Toole, T., Mair, M., & Inglesby, T. (2002). Shining light on 'Dark Winter'. Clinical Infectious Diseases, 34, 972-83.
234. Oldstone, M. (1998). Viruses, Plagues and History. Oxford: Oxford University Press.
235. Oleske, J., Minnefor, A., Cooper, R., Thomas, K., Cruz, A., Ahdieh, H. et al. (1983). Immune deficiency syndrome in children. Journal of the American Medical Association, 249, 2345-9.
236. Olson, K. (1999). Aum Shinrikyo: Once and future threat? Emerging Infectious Diseases, 5, 513-16.
237. Omran, A. (1971). The epidemiological transition: A theory of the epidemiology of population change. Millbank Memorial Fund Quarterly, 49, 509-38.
238. Omran, A. (1983). The epidemiological transition theory: A preliminary update. Journal of Tropical Pediatrics, 29, 305-16.
239. Oxford, J. (2001). The so-called great Spanish influenza pandemic of 1918 may have originated in France in 1916. Philosophical Transactions of the Royal Society of London Series B, 356, 1857-9.
240. Packard, R. (1989). White Plague, Black Labor: Tuberculosis and the Political Economy of Health and Disease in South Africa. Berkeley and Los Angeles: University of California Press.
241. Palumbi, S. (2001a). Humans as the world's greatest evolutionary force. Science, 293, 1786-90.
242. Palumbi, S. (2001b). The Evolution Explosion: How Humans Can Cause Rapid Evolutionary Change. New York: WW Norton and Co.
243. Park, K. (1993). Kimberley Bergalis, AIDS and the plague metaphor. In M. Garber, J. Matlock, & R. Walkowitz (eds), Media Spectacles. New York and London: Routledge, pp. 232-54.
244. Peden, A., Head, M., Richie, D., Bell, J. & Ironside, J. (2004). Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. The Lancet, 364, 527-9.
245. Pennington, T.H. (2003). When Food Kills: BSE, E. Coli and Disaster Science. Oxford: Oxford University Press.
246. Pernick, M. (2002). Contagion and culture. American Literary History, 14, 858-65. Peters, C., Johnson, E., Jahrling, P., Ksiazek, T., Rollin, P., White, J. et al. (1993). Filoviruses. In S.S. Morse (ed.), Emerging Viruses. Oxford: Oxford University Press, pp. 159-75.
247. Peters, C., Johnson, E., Jahrling, P., Ksiazek, T., Rollin, P., White, J. et al. (1993). Filoviruses. In S.S. Morse (ed.), Emerging Viruses. Oxford: Oxford University Press, pp. 159-75.
248. Pettifor, A. (2006). The Coming First World Debt Crisis. Basingstoke: Palgrave Macmillan.
249. Phillips, D. (1994). Epidemiological transition: Implications for health and health care provision. Geografiska Annaler Series B, Human Geography, 76, 71-89.
250. Piller, C. & Yamamoto, K. (1988). Gene Wars: Military Control Over the New Genetic Technologies. New York: Beech Tree Books.
251. Pisani, E. (2008). The Wisdom of Whores: Bureaucrats, Brothels, and the Business of AIDS. London: Grant Books.
252. Poirier, R. (1988). AIDS and traditions of homophobia. Social Research, 55, 461-75.
253. Poltorak, M., Leach, M., Fairhead, J., & Cassell, J. (2005). 'MMR talk' and vaccination choices: An ethnographic study in Brighton. Social Science and Medicine, 61, 709-19.
254. Preston, R. (1995). The Hot Zone: A Terrifying True Story. New York: Knopf Doubleday.
255. Preston, R. (1997). The Cobra Event. Toronto and New York: Random House.
256. Proctor, R. (1995). CancerWars: How Politics Shapes WhatWe Know and Don't Know About Cancer. New York: Basic Books.
257. Read, T., Salzberg, S., Pop, M., Shumway, M., Umayam, L., Jiang, L. et al. (2002). Comparative genome sequencing for discovery of novel polymorphisms in Bacillus anthracis. Science, 296, 2028-33.
258. Reichman, L. & Tanne, J. (2002). Timebomb: The Global Epidemic of Multi drug Resistant Tuberculosis. New York: McGraw Hill.
259. Renne, E. (2006). Perspectives on polio and immunization in northern Nigeria. Social Science and Medicine, 63, 1857-69.
260. Rice, L. (2001). Emergence of vancomycin-resistant enterococci. Emerging Infectious Diseases, 7, 183-7.
261. Roberts, C. & Cox, M. (2003). Health and Disease in Britain: From Prehistory to the Present Day. Stroud: Sutton Publishing.
262. Rook, A. & Stanford, J. (1998). Give us this day our daily germs. Immunology Today, 19, 113-16.
263. Rosenberg, BH (2002, 22 September). Anthrax attacks push open an ominous door. Los Angeles Times.
264. Ryan, F. (1992). The Forgotten Plague: How the Battle Against TuberculosisWasWon - and Lost. Boston, Toronto and London: Little Brown and Company.
265. Sabatier, R. (1988). Blaming Others: Prejudice, Race and Worldwide AIDS. London: Panos Publications Ltd.
266. Sachs, J. (2007). Good Germs, Bad Germs: Health and Survival in a Bacterial World. New York: Hill and Wang.
267. Said, E. (1978). Orientalism. London: Penguin Books.
268. Salkin, A (2006, 11 May). Germs never sleep. The New York Times.
269. Sarasin, P. (2006). Anthrax: Bioterror as Fact and Fantasy. Cambridge, MA: Harvard University Press.
270. Schaub, B., Lauener, R., & von Mutius, E. (2006). The many faces of the hygiene hypothesis. The Journal of Allergy and Clinical Immunology, 117, 969-77.
271. Schiller, N., Crystal, S., & Lewellen, D. (1994). Risky business: The cultural construction of AIDS risk groups. Social Science & Medicine, 38, 1337-46.
272. Scholten, B. (2007). Dirty Cows: Perceptions of BSE/vCJD. In B. Campkin & R. Cox (eds), Dirt: New Geographies of Cleanliness and Contamination. London and New York: IB Tauris, pp. 189-97.
273. Schwartz, B. & Yogev, R. (1996). An epidemic of emerging infectious diseases? Seminars in Pediatric Infectious Diseases, 7, 226-30.
274. Scott, C. (1896). Old age and death. American Journal of Psychology, 8, 67-122.
275. Shapiro, R. (2008). Suckers: How Alternative Medicine Makes Fools of Us All. London: Harvill Secker.
276. Shears, P. (2007). Poverty and infection in the developing world: Healthcarerelated infections and infection control in the tropics. Journal of Hospital Infection, 67, 217-24.
277. Shell, R. (2000). Halfway to the holocaust: The economic, demographic and social implications of the AIDS pandemic to the year 2010 in the Southern African region. In HIV/AIDS: A Threat to the African Renaissance? Konrad-Adenauer- Stiftung Occasional Papers, June.
278. Shilts, R. (1987). And the Band Played On: Politics, People and the AIDS Epidemic. New York: Penguin Books.
279. Shnayerson, M. & Plotkin, M. (2002). The Killers Within: The Deadly Rise of Drug Resistant Bacteria. Boston, New York and London: Little Brown and Company.
280. Shohat, E. & Stam, R. (1994). Unthinking Eurocentrism: Multiculturalism and the Media. London: Routledge.
281. Shove, E. (2003). Comfort, Cleanliness and Convenience: The Social Organization of Normality. Oxford: Berg.
282. Showalter, E. (1997). Hystories: Hysterical Epidemics and Modern Media. New York: Columbia University Press.
283. Sidel, V., Hillel, W., & Gould, R. (2001). Good intentions and the road to bioterrorism preparedness. American Journal of Public Health, 91, 716-17.
284. Singel, L. & Lashley, F. (2009). Cholera. In F. Lashley & J. Durham (eds), Emerging Infectious Diseases: Trends and Issues. New York: Springer Publishing Company, pp. 73-82.
285. Singer, M. & Clair, S. (2003). Syndemics and public health: Reconceptualizing disease in a bio-social context. Medical Anthropology Quarterly, 17, 423-41.
286. Singh, J., Hallmayer, J., & Illes, J. (2007). Interacting and paradoxical forces in neuroscience and society. Nature Reviews Neuroscience, 8, 153-60.
287. Smallman-Raynor, M. & Cliff, A. (2003). War and disease: Some perspectives on the spatial and temporal occurence of tuberculosis in wartime. In M. Gandy & A. Zumla (eds), The Return of the White Plague: Global Poverty and the 'New' Tuberculosis. London: Verso, pp. 70-94.
288. Smith, P. (2001). Cultural Theory: An Introduction. Malden, MA: Blackwell Publishers.
289. Smith, V. (2007). Clean: A History of Personal Hygiene and Purity. Oxford: Oxford University Press.
290. Smith-Nonini, S. (2004). The cultural politics of institutional responses to resurgent tuberculosis epidemics: New York City and Lima, Peru. In R. Packard, P. Brown, R. Berkelman, & H. Frumkin (eds), Emerging Illness and Society: Negotiating the Public Health Agenda. Baltimore and London: The Johns Hopkins University Press, pp. 253-90.
291. Sontag, S. (1978). Illness as Metaphor. London: Penguin Books.
292. Sontag, S. (1989). AIDS and its metaphors. (Penguin Books 1991 ed.) USA: Farrar, Straus & Giroux.
293. Spier, R. (2002). Perception of risk of vaccine adverse events: A historical perspective. Vaccine, 20, S78-S84.
294. Spurgeon, D. (2007). Prevalence of MRSA in US hospitals hits a new high. British Medical Journal, 335, 961.
295. Stanford, J. & Grange, J. (1991). Is Africa lost? The Lancet, 338, 557-9.
296. Stern, J. (1999). The Ultimate Terrorists. Cambridge, MA: Harvard University Press.
297. Stern, V. (2003). The House of the Dead revisited: Prisons, tuberculosis and public health in the former Soviet bloc. In M. Gandy & A. Zumla (eds), The Return of the White Plague: Global Poverty and the 'New' Tuberculosis. London: Verso, pp. 178-94.
298. Stetten, D. (1980). Eradication. Science, 210, 1203.
299. Stokes, G. (2002). Microbial resistance to antibiotics. In F. Lashley & J. Durham (eds), Emerging Infectious Diseases: Trends and Issues. New York: Springer Publishing Company, pp. 23-42.
300. Strachan, D. (1989). Hay fever, hygiene, and household size. British Medical Journal, 299, 1259-60.
301. Streefland, P., Chowdhury, A., & Ramos-Jimenez, P. (1999). Patterns of vaccination acceptance. Social Science and Medicine, 49, 1705-16.
302. Strong, P. (1990). Epidemic psychology: A model. Sociology of Health and Illness, 12, 249-59.
303. Tartasky, D. (2002). Escherichia coli O157:H7. In F. Lashley & J. Durham (eds), Emerging Infectious Diseases: Trends and Issues. New York: Springer Publishing Company, pp. 129-38.
304. Taubenberger, J., Reid A.H., Janczewski A. & Fanning T.G. (2001). Integrating historical, clinical and molecular genetic data in order to explain the origin and virulence of the 1918 Spanish influenza virus. Philosophical Transactions of the Royal Society of London Series B, 356, 1829-39.
305. Tauxe, R. (1997). Emerging foodborne diseases: An evolving public health challenge. Emerging Infectious Diseases, 3, 425-34.
306. Taylor, L., Latham, S., & Woolhouse, E. (2001). Risk factors for human disease emergence. Philosophical Transactions of the Royal Society of London, 356, 983-9.
307. The BSE Inquiry (2000). Report, Evidence and Supporting Papers of the Inquiry into the Emergence and Identification of Bovine Spongiform Encephalopathy (BSE) and Variant Creutzfeldt-Jakob Disease (vCJD) and the Action Taken in Response to it up to 20 March 1996. London: HMSO.
308. The National Creutzfeldt-Jakob Disease Surveillance Unit (2009). vCJD worldwide. The University of Edinburgh (On-line). Available: http://www.cjd.ed. ac.uk/.
309. Tiffin, H. (2007). Foot in Mouth: Animals, disease and the cannibal complex. Mosaic, 40, 11-16.
310. Tognotti, E. (2003). Scientific triumphalism and learning from the facts: Bacteriology and the 'Spanish flu' challenge of 1918. The Journal of the Society for the Social History of Medicine, 16, 97-110.
311. Treichler, P. (1999). How to Have Theory in an Epidemic: Cultural Chronicles of AIDS. Durham, NC: Duke University Press.
312. Treichler, P. (1988). AIDS gender and biomedical discourse: Current contests for meaning. In E. Fee & D. Fox (eds), AIDS: The Burdens of History. Berkeley: University of California Press, pp. 190-266.
313. Trotter, G. (2003). Emergency medicine, terrorism, and universal access to health care: A potent mixture for erstwhile knights-errant. In J. Moreno (ed.), In the Wake of Terror: Medicine and Morality in a Time of Terror. Cambridge, MA: The MIT Press, pp. 133-47.
314. Trust for America's Health (2006). Covering the pandemic flu threat: Tracking atricles and some key events, 1997 to 2005. Trust for American's Health (On-line). Available: http://healthyamericans.org/reports/flumedia/Covering Report.pdf.
315. Ungar, S. (1998). Hot crises and media reassurance: A comparison of emerging diseases and Ebola Zaire. British Journal of Sociology, 49, 36-56.
316. Urquhart, J. & Heilmann, K. (1984). Risk Watch; The Odds of Life. New York: Facts on File Publications.
317. Victor, T. & Young, D. (2005). Tackling the white plague: Multidrug-resistant tuberculosis. In G. Newton (ed.), Antibiotic Resistance: An Unwinnable War. London: The Wellcome Trust, pp. 29-31.
318. Vigarello, G. (1988). Concepts of Cleanliness: Changing Attitudes in France Since the Middle Ages. Cambridge: Cambridge University Press.
319. Wakefield, A., Murch, S., Anthony, A., Linnell, J., Casson, D., Malik, M. et al. (1998). Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. The Lancet, 351, 637-41.
320. Wallace, D. & Wallace, R. (1998). A Plague on Your Houses: How New York was Burned Down and Public Health Crumbled. London and New York: Verso.
321. Wallace, D. & Wallace, R. (2003). The recent tuberculosis epidemic in New York City: Warning from the de-developing world. In M. Gandy & A. Zumla (eds), The Return of the White Plague: Global Poverty and the 'New' Tuberculosis. London: Verso, pp. 125-46.
322. Wallis, P. & Nerlich, B. (2005). Disease metaphors in new epidemics: The UK media framing of the 2003 SARS epidemic. Social Science & Medicine, 60, 2629-39.
323. Washer, P. (2004). Representations of SARS in the British newspapers. Social Science & Medicine, 59, 2561-71.
324. Washer, P. (2006). Representations of mad cow disease. Social Science & Medicine, 62, 457-66.
325. Washer, P. & Joffe, H. (2006). The 'hospital superbug': Social representations of MRSA. Social Science & Medicine, 63, 2141-52.
326. Washer, P., Joffe, H., & Solberg, C. (2008). Audience readings of media messages about MRSA. Journal of Hospital Infection, 70, 42-7.
327. Watney, S. (1987). Policing Desire: Pornography, AIDS and the Media. London: Cassell.
328. Watney, S. (1989). Taking liberties. In E. Carter & S.Watney (eds), Taking Liberties: AIDS and Cultural Politics. London: Serpents Tail, pp. 11-58.
329. Watney, S. (1994). Practices of Freedom: Selected Writings on HIV/AIDS. London: Rivers Oram Press.
330. Weeks, J. (1993). AIDS and the regulation of sexuality. In V. Berridge & P. Strong (eds), AIDS and Contemporary History. Cambridge: Cambridge University Press, pp. 17-36.
331. Weinberg, J. & Simmonds, S. (1995). Public health, epidemiology and war. Social Science and Medicine, 40, 1663-9.
332. Weir, S. & Beetham, D. (1998). What the Public Give: Political Power and Accountability in British Government. London: Routledge.
333. Weisman, S.R (2005, 9 November). Powell calls his UN speech a lasting blot on his record. The New York Times.
334. Weiss, R. & McMichael, A. (2004). Social and environmental risk factors in the emergence of infectious diseases. Nature Medicine, 10, 1150.
335. Wellcome Witnesses to Twentieth Century Medicine (2000). Post Penicillin Antibiotics: From Acceptance to Resistance London: The Wellcome Institute.
336. Welshman, J. (2000). Tuberculosis and ethnicity in England and Wales, 1950-70. Sociology of Health and Illness, 22, 858-82.
337. Wetter, D., Daniell, W., & Treser, C. (2001). Hospital preparedness for victims of chemical or biological terrorism. American Journal of Public Health, 91, 710-16.
338. Widdus, R. (1999). The potential to control or eradicate infectious diseases through immunisation. Vaccine, 17, S6-S12.
339. Wilkinson, I. (2001). Social theories of risk perception: At once indispensable and insufficient. Current Sociology, 49, 1-22.
340. Williamson, J. (1989). Every virus tells a story: The meanings of HIV and AIDS. In E. Carter & S. Watney (eds), Taking Liberties: AIDS and Cultural Politics. London: Serpent's Tail, pp. 69-80.
341. Wilson, M. (1995). Travel and the emergence of infectious diseases. Emerging Infectious Diseases, 1, 39-46.
342. Winslow, C. (1943). The Conquest of Epidemic Disease: A Chapter in the History of Ideas. Wisconsin: University of Wisconsin Press.
343. Wolfe, R. & Sharp, L. (2002). Anti-vaccinationists past and present. British Medical Journal, 325, 430-2.
344. World Health Organization (1978). Declaration of Alma-Ata: International Conference on Primary Health Care, Alma-Ata, USSR, 6-12 September 1978 Geneva: World Health Organization.
345. World Health Organization (2003a). Cumulative Number of Reported Probable Cases of SARS from 1 Nov 2002 to 11 July 2003 Geneva: World Health Organization.
346. World Health Organization (2003b). Dr. Carlo Urbani of the World Health Organization Dies of SARS Geneva: World Health Organization.
347. World Health Organization (2003c). Severe Acute Respiratory Syndrome (SARS): Resolution of the 56th World Health Assembly (Rep. No. WHA56.29). Geneva: World Health Organization.
348. World Health Organization (2009). Confirmed Human Cases of Avian Influenza A (H5N1) Geneva: World Health Organization.
349. Wynia, M. (2006). Risk and trust in public health: A cautionary tale. The American Journal of Bioethics, 6, 3-6.
350. Zambon, M. & Nicholson, KG. (2003). Sudden acute respiratory syndrome. British Medical Journal, 326, 669.
351. Zinsser, H. (1935). Rats, Lice and History. London: George Routledge and Sons Ltd.